Xi'an Beilin Pharmaceutical Co.
Xi'an Beilin Pharmaceutical Co., founded in 1969, is a privately-held Chinese manufacturer of traditional Chinese medicines and health supplements, headquartered in Xi'an with 1,001-5,000 employees, serving consumer health needs through its long-established Beilin brand.
- Company typePrivate
- Founded1969
- HeadquartersXian Shi, China
- Headcount1,001–5,000
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What Xi'an Beilin Pharmaceutical Co. does
Xi'an Beilin Pharmaceutical Co., Ltd. (远大碑林(西安)药业有限公司) is a privately-held Chinese pharmaceutical manufacturer founded in 1969 and headquartered in Xi'an, Shaanxi Province. The company produces traditional Chinese medicines (TCM) and health supplements targeting a range of consumer health needs, operating under the long-standing Beilin (碑林) brand alongside the DBA 远大碑林药业 (Yuanda Beilin Pharmaceutical). The '远大' (Yuanda) prefix in the corporate name suggests potential affiliation with a larger Yuanda group, though no formal parent-subsidiary relationship, ownership structure, or capital structure is documented in available sources. The company maintains a workforce of 1,001-5,000 employees, indicating mid-sized manufacturing operations with established production capacity.
The company operates an active corporate website (beilinchina.cn) that surfaces a Products and Services section and a News section, although specific product names, formulations, therapeutic indications, technical manufacturing details, certifications, and pipeline information are not disclosed in the available source material. As a TCM producer, the company's operational backbone likely rests on regulated pharmaceutical manufacturing licenses, traditional formulation expertise, and brand equity built over more than five decades. The website's template-based structure and absence of disclosed product detail suggest a relatively traditional offline-anchored distribution model rather than a digitally-led consumer brand.
The business model of a mid-sized Chinese TCM manufacturer typically combines branded OTC pharmacy distribution, hospital channel sales, and selective e-commerce presence, with revenue mechanics driven by unit volume across therapeutic categories rather than enterprise contracts. However, no revenue figures, pricing tiers, go-to-market specifics, customer segments, or geographic distribution data are publicly disclosed. Ownership remains opaque with no disclosed funding rounds, M&A activity, leadership changes, or strategic milestones in the available data. The website appears active, indicating ongoing operations, but there is no public information on recent commercial initiatives to triangulate competitive positioning or growth direction.
Xi'an Beilin Pharmaceutical Co. firmographics
Firmographics- Name
- Xi'an Beilin Pharmaceutical Co.
- Legal name
- 远大碑林(西安)药业有限公司
- Website
- https://beilinchina.cn
- Company type
- Private
- Founded year
- 1969
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Xi'an Beilin Pharmaceutical Co., founded in 1969, is a privately-held Chinese manufacturer of traditional Chinese medicines and health supplements, headquartered in Xi'an with 1,001-5,000 employees, serving consumer health needs through its long-established Beilin brand.
- Ownership category
- akta.pro rank
Xi'an Beilin Pharmaceutical Co. industry classification
Industry- Product category
- Traditional Chinese Medicine Manufacturing
- NAICS
- Pharmaceutical and Medicine Manufacturing (32541), Pharmaceutical and Medicine Manufacturing (3254), Medicinal and Botanical Manufacturing (325411), Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)
Keywords
Where Xi'an Beilin Pharmaceutical Co. is headquartered
LocationHeadquarters
- HQ city
- Xian Shi
- HQ country
- China
- HQ region
- Asia
Offices1 record
Markets served
Xi'an Beilin Pharmaceutical Co. business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Operations, Marketing or Sales
Xi'an Beilin Pharmaceutical Co. product offering
Product offeringCore offering
Xi'an Beilin Pharmaceutical Co. is a Chinese pharmaceutical manufacturer that produces and sells traditional Chinese medicines and herbal health supplements under the Beilin (碑林) brand. Founded in 1969 and based in Xi'an, Shaanxi Province, the company operates manufacturing facilities staffed by 1,001–5,000 employees to serve domestic pharmaceutical and consumer health markets in China.
Product overview
远大碑林(西安)药业有限公司 (Yuanda Beilin (Xi'an) Pharmaceutical Co., Ltd.) operates a website at https://beilinchina.cn/ featuring a Products and Services section and News section. The source content contains primarily template placeholders with no specific product names, detailed descriptions, or architectural information available for extraction.
Differentiator
Problem solved
Functional benefit
Products and services
- Traditional Chinese Medicines Branded traditional Chinese medicine formulations manufactured by Xi'an Beilin Pharmaceutical Co. and sold under the Beilin (碑林) name for treatment of common ailments and traditional therapeutic indications. Targeted at domestic Chinese distributors, hospital and retail pharmacies, and end consumers.
- Herbal Health Supplements
Companies that use Xi'an Beilin Pharmaceutical Co.
Customer profileIdeal customer profiles2 records
Xi'an Beilin Pharmaceutical Co. technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Xi'an Beilin Pharmaceutical Co. partnerships and signals
Strategic signalRecent moves2 records
Expansion highlights2 records
Xi'an Beilin Pharmaceutical Co. competitors and assessment
Company assessmentDirect peers
- Livzon Pharmaceutical Group: Chinese pharmaceutical group combining TCM, chemical drugs, and APIs. Comparable as a diversified manufacturer with a meaningful TCM franchise alongside broader pharmaceutical operations.
- Yunnan Baiyao Group: One of China's largest TCM manufacturers, producing proprietary Chinese medicines and health products. Directly comparable as a branded TCM manufacturer with established domestic scale and growing consumer health reach.
- China Beijing Tongrentang (Group): Iconic TCM manufacturer with a 350+ year heritage, producing classical Chinese medicines and health products. Comparable as a long-established branded TCM player with strong domestic and growing international footprint.
- Pien Tze Huang (Pi Zhu Tang): Specialty TCM manufacturer known for a single flagship formula, but operating in the same branded Chinese medicine manufacturing space with similar regulatory and distribution dynamics.
- Shandong Dong-E E-Jiao: Vertically integrated TCM manufacturer specializing in ejiao and related healthcare products. Comparable as a heritage Chinese medicine producer with branded consumer health positioning.
- Guangzhou Pharmaceutical Holdings (GPHL / Huangshangji): Major Chinese TCM and chemical drug manufacturer, with brands including Huangshangji and Wanglaoji. Comparable as a scaled TCM producer operating in both pharmaceutical and consumer health categories.
- Yiling Pharmaceutical (Shijiazhuang Yiling): TCM innovator focused on cardiology and oncology formulas; comparable to Beilin as a mid-large traditional Chinese medicine manufacturer transitioning toward evidence-based modernized formulations.
Broad incumbents
- Jiangsu Yangtze River Pharmaceutical (Yangzi River Pharma): Large privately-held Chinese pharmaceutical manufacturer with both TCM and chemical drug operations. Comparable in scale and domestic manufacturing footprint to a mid-tier TCM player like Beilin.
- China Resources Pharmaceutical Group: State-backed pharmaceutical conglomerate with TCM and western medicine manufacturing. Comparable as a diversified large-scale player covering the same regulatory and distribution environment as Beilin.
- Shanghai Pharmaceuticals Holding: One of China's largest pharmaceutical conglomerates with a significant TCM franchise. Comparable as a broad incumbent operating Chinese medicine manufacturing as part of a wider prescription and consumer health portfolio.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
Xi'an Beilin Pharmaceutical Co. financial estimates
Financial estimateRevenue estimate
Valuation estimate
Xi'an Beilin Pharmaceutical Co. leadership team
Management profileNumber of profiles
Xi'an Beilin Pharmaceutical Co. funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Xi'an Beilin Pharmaceutical Co. M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Xi'an Beilin Pharmaceutical Co.
What does Xi'an Beilin Pharmaceutical Co. do?
Xi'an Beilin Pharmaceutical Co. is a Chinese pharmaceutical manufacturer that produces and sells traditional Chinese medicines and herbal health supplements under the Beilin (碑林) brand. Founded in 1969 and based in Xi'an, Shaanxi Province, the company operates manufacturing facilities staffed by 1,001–5,000 employees to serve domestic pharmaceutical and consumer health markets in China.
When was Xi'an Beilin Pharmaceutical Co. founded?
Xi'an Beilin Pharmaceutical Co. was founded in 1969. It employs 1,001 to 5,000 people.
Where is Xi'an Beilin Pharmaceutical Co. based?
Xi'an Beilin Pharmaceutical Co. is headquartered in Xian Shi, China, in the Asia region.
Who are Xi'an Beilin Pharmaceutical Co.'s main competitors?
Direct peers on record are Livzon Pharmaceutical Group, Yunnan Baiyao Group, China Beijing Tongrentang (Group), Pien Tze Huang (Pi Zhu Tang), Shandong Dong-E E-Jiao, Guangzhou Pharmaceutical Holdings (GPHL / Huangshangji) and Yiling Pharmaceutical (Shijiazhuang Yiling). Broad incumbents are Jiangsu Yangtze River Pharmaceutical (Yangzi River Pharma), China Resources Pharmaceutical Group and Shanghai Pharmaceuticals Holding.
Does Xi'an Beilin Pharmaceutical Co. have an API?
No public API is recorded for Xi'an Beilin Pharmaceutical Co..
What industry is Xi'an Beilin Pharmaceutical Co. in?
Xi'an Beilin Pharmaceutical Co.'s product category is Traditional Chinese Medicine Manufacturing. Its primary akta.pro industry code is HLAIABAH, Generic Finished Dosage Form (FDF) Manufacturing. Its NAICS code is 32541 and its SIC code is 2834.